Navigation Links
KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010
Date:12/22/2009

ST. LOUIS, Dec. 22 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

In the event the Company is unable to file the 2009 Annual Report on or prior to March 31, 2010, the Company may request that the Exchange permit the Company's securities to continue to trade on the Exchange until June 17, 2010. In the event the Company is unable to file the 2009 Annual Report prior to June 17, 2010 (or prior to March 31, 2010 in the event the Company requests that the Exchange permit the Company's security to continue to trade on the Exchange until June 17, 2010 and such request is not granted by the Exchange), the Exchange will initiate suspension and delisting procedures.

As previously disclosed by the Company on its Form 12b-25 filed with the SEC on June 2, 2009, as well as in subsequent filings with the SEC, the Company has been unable to file its 2009 Annual Report. The Company's Current Report on Form 8-K filed with the SEC on November 12, 2009 sets forth additional information regarding the Company's inability to timely file the 2009 Annual Report, certain other periodic reports, and related matters.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx Corporation, the company's branded drug subsidiary.

For further information about KV
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... Tuesday, August 4 at 11:30 a.m. Eastern Time to ... on pipeline and business progress.  Interested ... or access the webcast at www.isispharm.com .  A ... at the same address. ABOUT ISIS PHARMACEUTICALS, ...
(Date:7/28/2015)... Calif. , July 28, 2015 ... that it will report its second quarter 2015 financial ... 2015.  Rigel senior management will follow the announcement ... 4:30pm Eastern Time (1:30pm Pacific Time) to discuss ... the live conference call by dialing 855-892-1489 (domestic) ...
(Date:7/27/2015)... , July 28, 2015 CTI BioPharma ... plans to report its second quarter 2015 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 3Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2
(Date:7/28/2015)... ... July 28, 2015 , ... Bipolar disorder is often associated with ... a few times a year. The World Health Organization (WHO) has reported that bipolar ... of Mental Health reveals that the United States has the highest lifetime rate of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Brookstone®, ... Aligner System to its online product offerings, giving its customers the opportunity ... and cloud-based technology, SmileCareClub allows patients to get quality, remote invisible aligner treatment ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... Board of Directors has authorized the Company, from time to time and depending ... aggregate value of up to $25 million. Repurchases will be made in open ...
(Date:7/28/2015)... ... July 28, 2015 , ... Care ... proprietary, web based clinical knowledge system, called “Referral Guidance.” , Referral ... provides physicians who are anticipating making a subspecialty referral an efficient means to ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Fertility ... chosen as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top ... by hundreds of her esteemed colleagues and peers in the metro area as one ...
Breaking Medicine News(10 mins):Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... (TSX: DDS, NASDAQ: DDSS ), at the request ... Exchange, today commented on the recent trading activity of ... any reason for the recent trading activity other than ... date for its once-daily formulation of tramadol, by which ...
... and vitamin D in fight against osteoporosis, study finds ... protein and cereal grains causes excess acid production in the ... in weakened bones. , However, a new study finds that ... of fruits and vegetables can strengthen bones. , The study ...
... in Detroit will receive new winter jackets as well as ... presented by the Wayne County,Medical Society Foundation from 10:30 a.m. ... Science Center at 5020 John R at the intersection of ... Physicians, medical students, physician spouses and staff of the Wayne,County ...
... leading disability representation services company, explains the repercussions and risks of waiting ... ... -- Many people make the mistake of waiting too long to apply ... tens of thousands of people in the Social Security Disability Insurance ...
... promise against the disease, researchers report , , ... to test the mettle of breakthrough breast cancer ... medical landscape by drastically reducing the risk of ... Encouraging findings on several different drugs were presented ...
... OKEMOS, Mich., Dec. 11 Looking for some creative stocking-,stuffer ideas to keep ... Delta Dental of Michigan, Ohio and Indiana recommends the following gift,ideas ... , -- Musical Toothbrushes, ... recommended 2 minutes. A musical toothbrush is a great ...
Cached Medicine News:Health News:Labopharm Comments on Recent Trading Activity 2Health News:Fruits and Veggies May Strengthen Bones 2Health News:Time is Money When People Wait Too Long to Apply for Social Security Disability Benefits 2Health News:Time is Money When People Wait Too Long to Apply for Social Security Disability Benefits 3Health News:Time is Money When People Wait Too Long to Apply for Social Security Disability Benefits 4Health News:Osteoporosis Drug Seems to Shrink Breast Tumors 2Health News:Osteoporosis Drug Seems to Shrink Breast Tumors 3
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... Providing the surgical versatility you demand ... fractures.,The new EBI OsteoGen-D offers 40 microamperes ... leads each with 20 microamperes. Available in ... provides superior flexibility with any of your ...
... of patients requiring cataract surgery following refractive ... created a challenge for surgeons, as calculating ... difficult. True corneal power following RK, ALK, ... measure by keratometry or topography. For example, ...
... Stryker is proud to ... resectoscopes on the market at ... ergonomic design incorporates a superior ... and intuitive locking mechanisms. The ...
Medicine Products: